The health halo around red wine keeps fading. Large population studies comparing drinkers and abstainers now report little to no net advantage for a nightly glass once lifestyle, diet and baseline cardiovascular risk are controlled.
Antioxidants in red wine look potent in vitro, but the human gut and liver change that story. Polyphenols are poorly absorbed, rapidly metabolized and cleared, so their effective plasma concentration is far lower than in lab assays that measure oxidative stress. Meanwhile, every glass delivers ethanol, which raises blood pressure, promotes atrial fibrillation and adds empty calories that push body mass index and basal metabolic rate in the wrong direction for long term risk reduction.
When researchers adjust for confounders such as smoking, exercise, income and overall dietary pattern, the apparent benefit of light drinking largely disappears, exposing a classic selection bias rather than a protective effect. Red wine also competes with healthier sources of polyphenols, including berries and tea, which provide similar compounds without acetaldehyde exposure, hepatic fat accumulation or higher breast and colon cancer risk. In cost benefit terms, the marginal effect of its antioxidants is outweighed by the systemic effects of alcohol metabolism, leaving water the safer default for cardiovascular prevention.
